Basic info
Industry
biotechnology research
Sectors
Biotechnology
CRO
Biomimicry
Anti-metastatic target discovery
Microfluidics
Immuno-Capture
Date founded
2017
Funding rounds raised
Total raised
$390K
from 1 investors over 1 rounds
T
TumorGen, Inc. raised $390K on August 26, 2021
Investors: National Cancer Institute